OrbiMed’s BioXcel Therapeutics BTAI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,706	Closed	-$2.4M	–	138
2020 Q1	$2.4M	Buy	+6,706	New	+$2.4M	0.04%	122